Lv76
4970 积分 2022-11-04 加入
On the impact of KRAS(G12D) subtype non-small cell lung cancer
21天前
已完结
Recent advances in therapeutic targeting of the KRAS pathway in cancer
21天前
已完结
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS(G12D)-mutant pancreatic cancer: a phase 1b/2 trial
21天前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
21天前
已完结
The KRASG12D Inhibitor Pipeline Grows
21天前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RAS(G12D) aspartic acid in tumors
21天前
已关闭
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial
21天前
已完结
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
21天前
已完结
Tumor cell-derived LC3B(+)extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90α-IL-6/IL-8 signaling axis
22天前
已完结
A study on the correlation between longitudinal inflammatory biomarkers and postoperative prognosis in hepatocellular carcinoma
22天前
已完结
皖公网安备34019202002308
